The need for pulmonary rehabilitation following tuberculosis treatment

Affiliations

¹ Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese-Como.
² Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
³ Public Health Consulting Group, Lugano, Switzerland.
⁴ Tuberculosis Clinic, Instituto Nacional De Enfermedades Respiratorias Ismael Cosio Villegas, Ciudad De Mexico, Mexico.
⁵ International Union Against Tuberculosis and Lung Disease, Paris, France, Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya.
⁶ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.
⁷ Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy, <email></email>, Email: giovannibattista.migliori@icsmaugeri.it.

Comment

D Visca et al. Int J Tuberc Lung Dis. 2020.

. 2020 Jul 1;24(7):720-722.

doi: 10.5588/ijtld.20.0030.

¹ Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese-Como.
² Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
³ Public Health Consulting Group, Lugano, Switzerland.
⁴ Tuberculosis Clinic, Instituto Nacional De Enfermedades Respiratorias Ismael Cosio Villegas, Ciudad De Mexico, Mexico.
⁵ International Union Against Tuberculosis and Lung Disease, Paris, France, Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya.
⁶ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.
⁷ Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy, <email></email>, Email: giovannibattista.migliori@icsmaugeri.it.

No abstract available

Comment in

Treatment success, but living with the consequences of post-tuberculosis sequelae.
Tadyanemhandu C, Chirenda J, Garvey C, Metcalfe J. Tadyanemhandu C, et al. Int J Tuberc Lung Dis. 2020 Jul 1;24(7):657-658. doi: 10.5588/ijtld.20.0143. Int J Tuberc Lung Dis. 2020. PMID: 32718395 Free PMC article. No abstract available.

Should we consider a 'fourth 90' for tuberculosis?
Harries AD, Dlodlo RA, Brigden G, Mortimer K, Jensen P, Fujiwara PI, Castro JL, Chakaya JM. Harries AD, et al. Int J Tuberc Lung Dis. 2019 Dec 1;23(12):1253-1256. doi: 10.5588/ijtld.19.0471. Epub 2019 Nov 21. Int J Tuberc Lung Dis. 2019. PMID: 31753065